The SociumTeam
Socium’s leadership team and advisory board members have decades of experience in immunotherapy, vaccine development, translational research, clinical program implementation and intellectual property protection.
Timothy M. Salmon, JD
Co-founder, President & Chief Executive Officer
Robert G. Schaut, PhD
Immunologist
Daniel Mitry, JD
Co-founder, VP of Business Development
Debasish Roychowdhury, MD
Advisory Board Member
Anna Ferrari, MD
Advisory Board Member
Professor Joachim Fensterle, PhD
Advisory Board Member
Marcela F. Pasetti, PhD
Advisory Board Member
James E. Galen, PhD
Advisory Board Member
News
Latest News
Socium Therapeutics Selected to Represent New Jersey at BIO 2019
May 24, 2019 -- Today, the New Jersey Economic Development Authority (NJEDA) announced that Socium Therapeutics, Inc. is one of five biotech startups selected to represent New Jersey at the 2019 BIO International Convention in Philadelphia, PA. The NJEDA selected...
James E. Galen, PhD joins Advisory Board of Socium Therapeutics
May 8, 2018 -- Today, Socium Therapeutics announced that James E. Galen, PhD joined the company's Scientific Advisory Board. Dr. Galen has focused on the construction of attenuated bacterial vaccines and their use as live vectors to deliver foreign antigens to the...
Socium Therapeutics Selected to Present at BIO Investor Forum 2018
October 1, 2018 -- Socium Therapeutics has been selected to present at the BIO Investor Forum in San Francisco on October 18, 2018. Tim Salmon, CEO of Socium, commented, "I'm really excited to present in San Francisco. We have been meeting with many venture funds and...
Contact
Get InTouch
Email:
Phone:
(973) 585-6202
Address:
90 E. Halsey Road
Suite 311
Parsippany, NJ 07054
